# SpyGlass Pharma, Inc.: Form 8-K, filed Mar 26, 2026

- Company: [SpyGlass Pharma, Inc.](/companies/sgp.md) (CIK 1778922)
- Form: 8-K
- Filed: 2026-03-26
- Accepted by EDGAR: Mar 26, 2026, 20:06 ET
- Period: 2026-03-26
- Accession: 0001778922-26-000018
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1778922/000177892226000018/sgp-20260326.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1778922/000177892226000018/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1778922/000177892226000018/sgp-20260326.htm

Filed Mar 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001778922-26-000018. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.